80 results
Page 2 of 4
424B5
zt0b sp4ccrk0jbyshls
16 Mar 22
Prospectus supplement for primary offering
8:00am
8-K
EX-10.1
rdm3vmdf6xcgtp1e7s
7 Feb 22
Axcella Therapeutics Announces Appointment of New Chief Financial Officer
4:00pm
8-K
EX-10.1
6cgm60jgg5
7 Dec 21
Departure of Directors or Certain Officers
6:15am
8-K
EX-10.1
mx5z0 sel
7 Sep 21
Entry into a Material Definitive Agreement
4:16pm
8-K
EX-10.1
itnjon22y2iti
3 Mar 21
Axcella Announces Alison D. Schecter, M.D., as President of R&D
5:26pm
S-3
EX-4.4
atv v7zk7ez5gk
5 Jun 20
Shelf registration
5:02pm
S-3
EX-1.2
8zw3gbvewsdkyoej9ubl
5 Jun 20
Shelf registration
5:02pm
S-3
6ysospih68ahpk t8
5 Jun 20
Shelf registration
5:02pm
S-3
EX-4.3
uy8n3
5 Jun 20
Shelf registration
5:02pm
424B4
qut 30gce6tk
14 May 20
Prospectus supplement with pricing info
5:15pm